Search | SIU School of Medicine

Showing: 254 Results

Events

3rd Annual Kenniebrew-McNeese Health Equity Conference

Join SIU Medicine and community partners for the annual 2025 Dr. Alonzo Kenniebrew Lecture & Forum and the Kenniebrew-McNeese Conference FROM AWARENESS to ACTION: Creating the conditions for sustainable engagement and meaningful change This one-day, in-person conference is focused on advancing equity and justice work in medical education and in our communities. It is also a wonderful opportunity for physicians, resident physicians, medical students and educators who have interest in presenting in a supportive environment at a regional conference. Please register by February 7, 2025 Other

Events

3rd Annual Ronald Romanelli, MD Trauma Lectureship

Division of Orthopedic Surgery Visiting Professor Program presents the 3rd Annual Ronald Romanelli, MD Trauma Lectureship Monday, September 12, 2022, 7 a.m. - 3 p.m. Memorial Learning Center Room 2A Featuring Peter Cole, MD - Division Medical Director for HealthPartners Orthopaedic Medical Group; Chair, Department of Orthopaedics, Regions Hospital; Professor, University of Minnesota

Events

40th Annual Meeting of the Midwest Chapter of the American Academy of Psychiatry and the Law

Events

4th Annual Ronald Romanelli, MD Trauma Lectureship

The Division of Orthopedic Surgery presents the 4th Annual Ronald Romanelli, MD Trauma Lectureship on Monday, February 12, 2024 from 7:00 am - 1:00 pm in the Memorial Learning Center, Room 2A. This year's visiting professor is Lisa Blackrick, MD. More information here

Events

7th Annual Women in Medicine and Science Professional Development Conference - We Are Better Together: Learning, Growing, and Connecting

Join the SIU School of Medicine Alliance for Women in Medicine and Science (AWIMS) and the Office of Equity, Diversity & Inclusion for the 7th Annual Women in Medicine and Science Professional Development Conference where we are learning, growing, and connecting! We Are Better Together!

Events

8th Annual Women in Medicine and Science Professional Development Conference

Join the SIU School of Medicine Alliance for Women in Medicine and Science (AWIMS) and the Office of Equity, Diversity & Inclusion for a transformative day of professional development, networking, and advocacy. This year’s theme, "Advocacy and You: Finding Your Why and Your Voice to Enact Change," will empower attendees to become strong advocates in their fields and communities. EVENT HIGHLIGHTS Keynote Speaker: Dr. Eliza Chin, Executive Director, American Medical Women’s Association Panel Discussion: Experts will explore the power of advocacy in medicine and science Interactive Sessions: •

Events

A Critical Conversation About Antiracism, Equity, Diversity, and Inclusion

SPEAKER(S): Dr. Wendi Wills El-Amin, Dr. Kemia Sarraf, Dr. Vidhya Prakash, Dr. Christopher Smyre and Kelly Hurst Disclosure: Dr. Wendi Wills El-Amin, course director of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose. Speakers: Dr. Wendi Wills El-Amin, Dr. Kemia Sarraf, Dr. Vidhya Prakash, Dr. Christopher Smyre and Kelly Hurst, speakers for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose. Educational Objectives: Those participating in this activity should be able to Apply

Trial

Neurology

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Active recruiting

The purpose of this study is to compare the success of a single admnistration of Staccato alprazolam compared with placebo in rapidly terminating a seizure episode within 90seconds after IMP administration.

Trial

Simmons Cancer Institute

A Phase 1 Study of SGN-B6A in Advanced Solid Tumors

Active recruiting

This trial looks at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors (NSCLC, HNSCC).

Trial

Simmons Cancer Institute

A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417as Monotherapy, in Combination With Dexamethasone and Carfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)

Active recruiting

The purpose of the study is to test BGB-11417 (alone, with dexamethasone, and with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma who test positive for t(11;14). .

Search Results